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Are the presence of MODIC changes on
MRI scans related to “improvement” in low
back pain patients treated with lumbar
facet joint injections?
Matilde Bianchi1, Cynthia K. Peterson2*, Christian W. A. Pfirrmann3, Juerg Hodler4 and Jennifer Bolton5
Abstract
Background: Modic changes (MC) have been linked with low back pain (LBP) and worse outcomes from some
treatments. No studies have investigated the impact that MCs may have on patient outcomes from lumbar facet
injections. Therefore, the purpose of this study is to investigate whether the presence of Modic changes is related
to ‘improvement’ in patients undergoing imaging-guided lumbar facet injection therapy.
Methods: Outcomes from 226 patients with MRI scans within 3 months of their imaging-guided lumbar facet
injections were investigated to determine whether MCs are related to ‘improvement’ post injection. At 1 day, 1 week
and 1 month post injection the Patients Global Impression of Change scale answers were collected by postal
questionnaire. This was the primary outcome measure. The numerical rating scale for pain data was collected prior to
treatment and at the same post injection time points. The MRI scans were independently evaluated by two examiners
for the presence/absence of Modic changes and the type of Modic change if present. Kappa statistics were used for
reliability of diagnosis analysis. Chi-squared test and logistic regression analysis tested MCs with ‘improvement’.
Results: Intra- and inter-examiner reliability for the diagnosis of MCs was Kappa = 0.77 and 0.74. Intra- and inter-
examiner reliability for categorizing MCs was K = 0.77 and K = 0.78.
At 1 month post injection 45.2 % of patients without MCs reported clinically relevant ‘improvement’ compared to
34.2 % of patients with MC I and 32.1 % of patients with MC II. However, this did not reach statistical significance.
Logistic regression found that Modic changes were not predictive of ‘improvement’.
Conclusions: There was a tendency for patients without MCs to have better outcomes but this did not reach statistical
significance. The reliability of diagnosing MCs was substantial.
Background
Low back pain (LBP) is a common, disabling and costly
condition affecting the adult population. Currently 85 %
of patients seeking care for LBP are classified as having
non-specific LBP [1]. To provide better patient care, it
has become important to try to identify specific sub-
groups within this heterogeneous LBP population which
may require different or specific types of treatments.
Recently, Modic changes (MCs) have been one of the
new topics of interest investigated in the current spine
literature because of their suggested importance as a
specific cause of LBP [2, 3]. Modic changes are recog-
nized on magnetic resonance imaging (MRI) scans as
alterations in signal intensity of the bone marrow adja-
cent to a degenerated disc. There are three types of
Modic changes namely signs of bone marrow edema
(Modic type I), fat (Modic type II) and osseous sclerosis
(Modic type III) [4–7]. Modic type I (bone marrow
edema) has specifically been linked to LBP [2, 3, 7]. If
Modic changes are a specific cause of LBP it now be-
comes important to assess their influence, if any, on
LBP treatments and outcomes from specific treatments.
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In 2011 Jensen and Leboeuf-Yde [4] performed a sys-
tematic critical literature review to investigate if there
is evidence in the literature that the presence of MCs at
baseline is associated with a favourable outcome de-
pending on the treatment provided for LBP. The six
studies found were too few, too heterogeneous and
often lacking in adequate methodological rigour, to
make a definitive conclusion as to if and how MCs are
an indication for specific therapies for LBP. Since that
time, there is one additional randomized controlled
clinical trial (RCT) and two recent cohort studies [5–7]
evaluating the link between MCs and clinical outcomes.
The RCT compared rest therapy with exercise in patients
with Modic changes and found no significant differences
in outcomes between these two groups. However, the
treatments were not compared with patients who did not
have Modic changes. The cohort studies, using fairly large
sample sizes, showed that the presence of MC type I
changes, at least at baseline, was associated with a poor
outcome. However, specific treatments for the LBP were
not evaluated. Thus, investigation of the role that Modic
changes may have on treatment outcomes in LBP patients
remains in its infancy.
If Modic changes are a specific cause of LBP, it is hy-
pothesized that patients with MC type I, the inflammatory
stage of the disc degeneration process, may have less
favourable outcomes from imaging-guided facet joint in-
jections as these Modic changes may be an additional
cause for their LBP. In the literature there are currently no
studies clearly establishing factors linked with positive or
negative outcomes in the intervention of lumbar facet
joint steroid injections. Therefore the aim of this study is
to try to further the research on the importance of MCs in
a group of non-specific LBP patients treated with thera-
peutic imaging-guided lumbar facet joint injections.
The specific objectives for the study were: a) to deter-
mine the reliability of detecting MCs on magnetic reson-
ance (MRI) scans in patients receiving imaging-guided
lumbar facet injections; b) to determine whether there is
a difference in outcome between LBP patients with and
without MCs treated with therapeutic imaging-guided
lumbar facet injections.
Methods
Ethics approval
Ethics approval was obtained for all imaging-guided injec-
tions and collection of patient follow-up self-reported data
from the Orthopaedic University Hospital Balgrist and the
Canton of Zürich ethics committees (EK 12/2009). In-
formed consent was obtained from every patient.
Patients
Over 400 patients received imaging-guided lumbar facet
injections from June 2009 up to April 2013 at this
Hospital, and returned outcomes-based postal question-
naires. These lumbar facet injection patients are part of
the large, ongoing, imaging-guided therapeutic injections
outcomes database started at this hospital in 2009 as
part of the quality assurance procedures. These ques-
tionnaires included the patient’s global impression of
change (PGIC) scale, as well as the 0 to 10 Numerical
Rating Scale (NRS) for pain intensity, where 0 = no
pain and 10 = the worst pain imaginable. As this is a
specialized university orthopedic hospital, the majority
of patients are chronic.
Of these, a total of 226 patients met the inclusion and
exclusion criteria for entry into the study. All included
patients had lumbar spine MRI scans performed at this
Hospital within 3 months of the imaging-guided facet
injections. No distinction was made as to whether the
MRI scans were performed 3 months before or after the
intervention. The natural course of MCs is a long one,
and thus three months was not considered long enough
to influence the nature of the MC.
Exclusion criteria consisted of recent acute vertebral
fractures, surgical fusions, acute traumatic Schmorl’s
nodes, spinal infection or tumours. Patients for whom
the facet injection procedure was a contraindication,
such a pregnancy and anticoagulant therapy, were also
excluded from the study. A flow-chart of patient exclu-
sions is given in Fig. 1. Pain medication intake was not
an exclusion criterion.
Lumbar facet injection treatment
The interventions were done using fluoroscopy-guided
therapeutic lumbar facet joint injections performed by
musculoskeletal radiologists at this hospital. Under
sterile conditions (3x disinfection, sterile gloves, mask,
sterile covering), fluoroscopy-guided puncture of the
relevant facet joint/s were performed. Documentation
of the needle position was done with contrast medium
and slice imaging followed by injection of 40 mg Kenacort
(Triamcinoloni acetonium; Dermapharm AG, Huenenberg
AG, Switzerland) and 1 ml Ropivacaine (Naropin;
Astra-Zeneca, Södertälje, Sweden). The radiologists
performing these injections report that it is almost
always the most degenerated facet joint/s that are targeted
for treatment based on the referral requests from the
orthopedic surgeons and rheumatologists.
MRI procedure
All MRI scans were performed at this Hospital where there
are three MR scanners available (Siemens Magnetom
Avanto 1.5 T, Espree 1.5 T or Verio 1.5 T). Sagittal T1
weighted, sagittal T2 weighted and transverse T2 weighted
images were acquired. Protocol for the 1.5 T Avanto MR
scanner: Sagittal T2 weighted (TR/TE 3740 ms/118 ms,
field of view 300x300cm, slice thickness 4 mm, matrix
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512x256 pixels), sagittal T1 weighted images (TR/TE
500 ms/11 ms, field of view 300x300cm, slice thickness
4 mm, matrix 512x256 pixels) and transverse T2 weighted
sequences (TR/TE 3700 ms/115 ms, field of view
220x220cm, slice thickness 4 mm, matrix 512x256 pixels).
Patient outcomes
Patient’s variables included age (measured in years) and
sex (female vs. male). Data on the chronicity and the
reasons for low back pain were not available but it is
known that most patients referred to this specialized
orthopedic university hospital are chronic patients.
Overall improvement was evaluated through the use of
the PGIC scale taken at 1 day, 1 week and 1 month after
injection. The PGIC is a 7-point categorical scale including
responses from “much better” to “much worse”. For the
purpose of the present study a priori definition of clinical
importance consisted of only the scores of “much better”
and “better” on the PGIC scales. These responses were
considered clinically relevant “improvement” and this was
the primary outcome measure. “Slightly better” was not
considered as improvement. “Worsening” included the
scores of “slightly worse”, “worse” and “much worse”.
Based on this priori definition of clinical importance, the
PGIC results were analyzed as a dichotomous categorical
variable, 1 or 2 = yes (improved) and 3–7 = no (not im-
proved). This is consistent with the use of this scale in sev-
eral other studies [8–11]. The PGIC scale as the indicator
of clinically relevant ‘improvement’ has been validated
against other longer outcome measures [12]. The primary
outcome was ‘improvement’ at 1 month but it was con-
sidered important to also evaluate outcomes at 1 day
and 1 week as the infiltration contained both a short
acting anaesthetic and the longer acting corticosteroid.
The NRS questionnaire was completed by each patient
immediately prior to the injection procedure (baseline)
and again at 15–20 min after injection. It was also
completed at 1 day, 1 week and 1 month post injection.
The NRS for pain is a standard instrument (numeric
scale) which can be interpreted differently from patient
to patient. To compensate for this variability the percent
change in pain was calculated.
Unlike the NRS, the PGIC is specifically linked to the
conceptual framework of overall improvement including
disability levels. A close association between changes on
the NRS and the PGIC has been demonstrated [12–14].
Data collection
Data collection consisted of the evaluation of sagittal and
axial T1-weighted sequences, T2-weighted sequences and
fat suppressed images - when present - to determine:
a) presence or absence of Modic changes and
b) the type of Modic changes - type I (Fig. 2) and II
(Fig. 3) only – if present. In cases showing MRI
findings of both type I and II, the case was
categorized as Modic type I.
The presence of Modic changes was reported as
MCs vs. no MCs (YES/NO) and MC type I vs. MC type
II (I/II). MC type III was not taken into consideration
given its rarity.
The collection of MRI information was based on visual
impression and was performed blinded to the patient out-
comes by the first examiner (examiner 1). The first one
hundred MRI examinations were re-evaluated by a second
examiner (examiner 2) for inter-examiner reliability of de-
tecting and categorizing MCs. This examiner was also
blinded to the patient outcomes as well as to the MRI
findings of examiner 1. Moreover the same one hundred
of the MRI scans were re-evaluated more than 1 month
after the initial MRI analysis for intra-examiner reliability
by examiner 1. Finally, imaging characteristics were agreed
by consensus in the few cases with disagreement.
•130 were excluded because no MR scan and injections within 3 montha apart
489 patients that received lumbar facet injections between 2009 
and 2013
•55 patients were excluded because the MR scan was not performed at this Hospital
359 patients analysed
•78 patients were excluded because of the presence of acute vertebral fracture, 
surgical fusion, acute traumatic Schmorl's nodes, spinal infection and tumours
304 patients analysed
226 patients were included into the study
Fig. 1 Flow chart of inclusion process
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Fig. 2 a, b and c Modic type I changes. T1, T2 weighted and fat suppressed sagittal MR images of a patient demonstrating low signal intensity
adjacent to L2-3 disc on T1 weighted images (2a) and high signal intensity on both T2 weighted image (2b) and fat suppressed image (2c),
consistent with MC type I (marrow edema) at L2 through 3
Fig. 3 a and b Modic type II changes. T1 and T2 weighted sagittal MR images of a patient demonstrating high-signal intensity adjacent to the
L5-S1 disc confirms MC type II marrow replacement. The L5-SI disc space is also narrowed
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Statistical analysis
The SPSS version 17.0 program was used for data ana-
lysis and the statistical evaluation.
Descriptive statistics of age and gender were calculated.
Cohen’s Kappa statistic [15] was used to assess the
intra- and inter-examiner reliability of the identification
and categorization of MCs on MRI.
The Chi-squared test was used to explore the relation-
ship between the presence/absence of MCs and type of
MCs and “improvement” at 1 day, 1 week and 1 month.
A p value < 0.05 was considered to be statistically signifi-
cant. The presence and type of MCs were also compared
for “worsening” using the Chi-squared test at 1 day,
1 week and 1 month.
For the purpose of the study the differences in pain as
percent change in pain severity was calculated. The un-
paired t-test was then used to compare the differences in
change in pain intensity between patients with MC type
I and patients without MCs, between patients with MC
type I and patients with MC type II, and between patients
with presence of MCs (type I and type II) and patients
without MCs. Again a p value < 0.05 was considered to be
statistically significant.
A logistic regression analysis was used to fit a predict-
ive model given the variables of the study (independent
variable: presence/absence of MCs; outcome variables:
PGIC improvement yes/no). These results were pre-
sented as unadjusted and adjusted odds ratio (OR) with
confidence intervals (CI). All values were adjusted for
potential confounders (age and gender).
Results
Between the dates of June 2009 and April 2013, 489 pa-
tients received imaging-guided lumbar facet joint infil-
trations. Of these, 226 patients met the inclusion criteria
for the study and 61.1 % were female patients. The mean
age of all patients included in the study was 61.6 (SD ±
13.33) years with the youngest patient being 23 years old
and the oldest patient being 88 years old. Modic changes
were observed in 141 of the 226 patients examined
(62.4 %). Of these, 83 were Modic change type I
(36.72 %), 58 were Modic change type II (25.66 %) and
85 (37.61 %) presented with no Modic changes. There
was a statistically significant difference in the ages when
comparing patients with and without Modic changes. The
mean age for patients without Modic changes was 56.6
(SD = 14.01) years, for Modic type I patients it was 64.8
(SD = 12.52) years (p = 0.001) and for Modic type II pa-
tients the mean age was 64.2 (SD = 14.01) years (p = 0.01).
When using the Chi-squared test to compare gender with
the various Modic categories there was no significant
difference in the gender ratio between the categories.
There were no statistically significant differences in
the baseline NRS scores when comparing patients with
Modic I, Modic II, and no Modic changes. Modic I pa-
tients had a mean NRS score of 6.6 (SD = 2.37), Modic
II patients reported a mean score of 6.9 (SD = 2.06) and
patients without Modic changes had a mean score of
6.6 (SD = 2.19).
Intra- and inter-examiner reliability
One hundred MRI scans were independently assessed
by both examiners. The intra-examiner reliability for
the presence/absence of MCs was K = 0.77 and for
MC I vs. MC II K = 0.77 (p < 0.001). Inter-examiner
reliability was K = 0.74 for presence/absence of MCs
and K = 0.78 for MC I vs. MC II (p < 0.001). These
results demonstrate substantial agreement for both
intra- and inter- examiner reliability of detecting and
categorizing MCs.
Difference in outcome
The proportions (frequencies) of patients reporting “im-
provement” and “worsening” for the absence of MCs,
MC type I only, and MC type II only and presence of
MCs (type I and II) are shown in Table 1. The propor-
tion of patients ‘unchanged’ (PGIC responses of ‘slightly
better’ or ‘unchanged’) is not reported. A higher percent-
age of patients without Modic changes reported clinic-
ally relevant ‘improvement’ at 1 month post injection
but this did not reach statistical significance.
There was a tendency for the subgroup of patients
without MCs to maintain improvement obtained by the
intervention longer in time as compared to patients with
MC type I, MC type II and with the presence of MCs.
Nevertheless, at one month after the intervention, the
Table 1 Difference in outcome
No Modic changes (N = 85) % Modic I (N = 83) % Modic II (N = 58) % Modic positive (Modic I and II) (N = 141) % P value
Improved 1 Day 33.7 % 39.8 % 32.8 % 36.9 % 0.64
Improved 1 Week 41.5 % 40.2 % 37.5 % 39.1 % 0.37
Improved 1 Month 45.2 % 34.2 % 32.1 % 33.3 % 0.23
Worse 1 Day 10.8 % 9.6 % 5.1 % 7.7 % 0.44
Worse 1 Week 14.3 % 13.4 % 10.8 % 12.2 % 0.67
Worse 1 Month 17.0 % 14.0 % 16.1 % 14.8 % 0.66
Comparison of the proportion of patients with and without Modic changes reporting clinically relevant “improvement” or “worsening” at 1 day, 1 week and 1 month
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proportion of patients that reported a worse outcome in-
creased in all subgroups.
Prediction of outcome (improvement)
For the logistic regression analysis two different analyses
were conducted: a) improvement (yes/no) in patients
with MC type I were compared to patients without
MCs, at 1 day, 1 week and 1 month and b) improvement
(yes/no) in patients with MC type I were compared to
patients with MC type II, at 1 day, 1 week and 1 month
(Table 2).
In both analyses the PGIC’ results obtained when con-
trolling for age and gender for MC type I, at the three
data collection time points, did not demonstrate a sig-
nificant difference after lumbar facet injection therapy as
compared to patients without MCs and as compared to
patients with MC type II. However, a lower proportion
of patient with MC type I reported “improvement”, but
this did not reach statistical significance (wide confident
intervals) when comparing these patients versus patients
without MCs and versus patients with MC type II.
Evaluation for differences in percent change in pain se-
verity (NRS scores) in the group with MC type I only vs.
the no MCs group, the group with MC type I only vs. the
group with MC type II only, and in the group with the
presence of MCs of either type vs. the group with the ab-
sence of MCs are shown in Table 3. At one month, pa-
tients without MCs demonstrated a higher mean NRS
change score than patients with the presence of MCs
(11 % higher) and with MC type I only (14 % higher), but
this did not reach statistical significance (p = 0.07).
When comparing the mean NRS change scores of pa-
tients with MC type I versus patient with MC type II no
significance difference in percent change in pain severity
was found at all the follow-up periods.
Discussion
Because there has been a growing research interest in the
clinical relevance of Modic changes adjacent to degener-
ated discs as viewed on MRI [2, 3, 16–18], the purpose of
this study was to further this research by assessing how a
specific patient population, i.e., chronic patients with the
presence of MCs either type I only, type II only or with
MCs type I and II together, responded to therapeutic
imaging-guided lumbar facet joint injections, as compared
to patients without MCs. This is the first study trying
to make such a comparison. It was hypothesized that
because MCs have been linked with LBP in previous
studies [2, 3, 5] patients with MC type I changes may
have worse outcomes after therapeutic lumbar facet in-
jections as they may have two sources for their pain –
facet joints and bone marrow edema.
The results obtained in this study, which had a fairly
large sample size, did not find a clinically relevant link be-
tween Modic changes, even type I, and the outcomes after
therapeutic lumbar facet injections for any of the data col-
lection time points. It was hypothesized that MC type I
patients were likely to respond poorly as their MCs could
either be the only pain source or an additional pain source
along with the facet articulations [2, 3, 5, 17, 19]. Although
the mean NRS change score at 1 month for patients with-
out MCs was 14 % higher than the mean change score for
patients with MC type I (i.e., absence of MCs means more
pain reduction), this did not quite meet the criteria for
statistical significance as the p value was 0.07. Perhaps a
larger sample size would have resulted in this becoming
statistically significant, but that would not necessarily
mean that it was clinically relevant as the current sample
size included 141 patients with MCs. These results are in
contrast to the results reported for lumbar disc herniation
patients receiving an imaging-guided therapeutic nerve
root block where patients with Modic changes (types I
and II together) reported significantly worse outcomes
compared to lumbar disc herniation patients without
Modic changes at the 1 month data collection time point
[20]. Both studies used a very similar methodology and
identical outcome measures and data collection time
points. However, for the lumbar disc herniation patients
the MRI findings were linked to their clinical presentation
of specific radiculopathy, whereas with lumbar facet injec-
tion patients the clinical symptoms are not necessarily as
clear and injections are therefore usually done at the most
degenerated joints.
Reporting negative results in research studies is as im-
portant as reporting positive results. If replicated, nega-
tive studies can prevent unnecessary duplication of such
studies in the future so that researchers can focus on
other issues.
According to Modic et al. [18] the natural course of type
I change is replacement with type II over 14 to 36 months.
Table 2 Association with outcome (improvement) Modic I vs. no Modic changes and Modic I vs. Modic II
Modic I vs. No Modic Changes Modic I vs. Modic II
Unadjusted OR (95 % CI) Adjusted OR (95 % CI) Unadjusted OR (95 % CI) Adjusted OR (95 % CI)
1 Day 1.30 (0.69–2.44) 0.94 (0.48–1.86) 0.74 (0.37–1.49) 0.79 (0.37–1.57)
1 Week 0.82 (0.44–1.51) 0.69 (0.35–1.33) 0.89 (0.44–1.79) 0.94 (0.46–1.90)
1 Month 0.73 (0.39–1.39) 0.68 (0.35–1.32) 0.91 (0.44–1.90) 0.90 (0.43–1.89)
Unadjusted and adjusted (age and gender) odds ratios (OR) with 95 % confident interval (CI) for the association with improvement between Modic change type I
and no Modic changes as well as Modic I compared to Modic II at the various time points
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The latter remained stable over 2 to 3 years follow-up
evaluation. The exact etiologic mechanism or mecha-
nisms, while unknown, have been thought related to some
type of unusual stresses, micro or macro-instability or
microtrauma [19]. Recent studies suggest a genetic predis-
position in patients showing the presence of MCs at the
same level of disc degeneration or disc herniation [21, 22].
Moreover, Kjaer et al. [2] suggested that disc degeneration
in the presence of MCs has a specific clinical profile and
thus they concluded that a degenerated disc per se is a
fairly quiet disorder but it constitutes a true clinical entity
when MCs are also present. Unfortunately, they consid-
ered type I and type II Modic changes together for the
purpose of their study, so no more specific conclusion
could be drawn.
It has been found that MC type I are related to non-
specific LBP and degenerative disc disease [2, 3, 5, 17, 19]
but they have never been directly linked to pain arising
from the facet joints. The starting hypothesis that patients
with MC type I may have a less favourable outcome from
therapeutic imaging-guided facet joint injections, arose
from the idea that in those patients part of the LBP may
actually arise from the inflammatory changes in the disco-
vertebral region of the spine instead of, or in addition to,
the lumbar facet articulations. Thus a procedure direct to
the zygapophysial joints will not be as effective in
decreasing pain. The MCs identified on the MRI scans of
these patients were not necessarily at the same level as the
facet injections. This is not considered a limitation how-
ever as the purpose was to determine whether the pres-
ence of MCs anywhere in the lumbar spine may be
another source of the patient’s LBP. Additionally, the pres-
ence or absence of edema at the injected facet joints them-
selves was also not investigated as, although facet joint
edema has been observed [23] this is not nearly as com-
mon as MCs at the discovertebral junctions. The number
of patients with findings of facet joint edema in this
current study would have been very small. It would there-
fore require a very large sample size to obtain sufficient
patient numbers with lumbar facet joint edema to assess
outcomes when considering the frequency of this finding.
Limitations
Only approximately one third of the patients in this
study reported clinically significant improvement (PGIC
scores) after the therapeutic facet joint injections. Hence,
this reinforces the conflicting literature about non-
specific LBP and lumbar facet joint injections. It is im-
portant to take into consideration that this current study
was based on the hypothesis that the patients’ pain arose
from their facet joints, but no test, such as anesthetic
blocks of the lumbar medial branches, was performed to
really identify the source of pain. The selection of the
relevant facet articulations was based on imaging find-
ings of the most severely degenerated facet levels.
Whether or not this is correct needs further investiga-
tion. However, if the Modic changes were the main pain
source, this should not have influenced the results. Usu-
ally, just after a lumbar facet joint injection into a pain-
ful joint the perceived pain disappears quickly, due to
the action of the anesthetic, the real steroid effect is
noted after a few days and it can last from 1–2 months
to 1–2 years. Interestingly, Manchikanti et al. [24, 25]
found an equal effectiveness of local anesthetics with or
without steroid, indicating a lack of support for the
proposition of inflammation in the pain arising from the
lumbar facet joints.
Having a longer follow-up time period was not consid-
ered necessary for this current study because if the pres-
ence of Modic changes was an additional or significant
source of the patients’ low back pain, these Modic posi-
tive patients should have reported worse outcomes after
the facet joint injections within this 1 month time frame.
The anesthetic and corticosteroid medications do not
reach the disc and adjacent vertebral bodies when only
injected into the facet articulations and thus could not
affect the region of the Modic changes. The protocol
used for this current study, including the time periods
for the data collection, is also very similar to other pub-
lished studies [20, 26]. If effective, the local anesthetic
Table 3 Differences in percent change in pain severity (NRS
scores) Modic type I vs. no Modic changes, Modic type I vs.
Modic type II and Modic changes present (both types I and II)
and Modic changes absent
Number Mean SD
% NRS Change 1 day Modic I 81 35.46 39.35
No Modic 85 34.90 35.29
% NRS Change 1 Week Modic I 79 32.63 53.58
No Modic 84 43.93 20.53
% NRS Change 1 Month Modic I 77 22.99 56.50
No Modic 81 36.97 36.89
% NRS Change 1 Day Modic I 81 35.46 39.35
Modic II 57 39.51 37.80
% NRS Change 1 Week Modic I 79 32.63 53.58
Modic II 55 45.19 39.68
% NRS Change 1 Month Modic I 77 22.99 56.50
Modic II 54 30.52 42.56
% NRS Change 1 Day Modic I & II 138 37.13 38.63
Modic Absent 85 34.90 35.29
% NRS Change 1 Week Modic I & II 134 37.78 48.59
Modic Absent 84 43.93 30.53
% NRS Change 1 Month Modic I & II 131 26.09 51.17
Modic Absent 81 36.97 36.89
N number of patients, NRS numerical rating scale for pain, SD standard deviation
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reduces the pain quickly (i.e., 1 day outcomes) whereas
the effects of the corticosteroid injected into the facet ar-
ticulations, would appear at the 1 week and 1 month
data collection time points. If the corticosteroid was go-
ing to work, it would have worked by 1 month in the
targeted injection site.
Including additional outcome measures such as a larger
disability questionnaire would be desirable. However,
over-all disability is part of the Patient’s Global Impression
of Change’ scale rating and asking the patient to rate their
level of function as part of over-all improvement is in the
instructions to the patient. This radiology department
tested using the Oswestry questionnaire during a pilot
study prior to starting the large outcomes database. It was
found that this relatively short questionnaire was still too
time consuming and disruptive to the flow of this busy
department.
Although mistakes could have been made during the
interpretation of the MRI studies due to the fact that
to define MCs the study is based only on visual im-
pression, the reliability results for detecting and classi-
fying MCs obtained in this study are good, showing a
high “substantial” level of inter and intra-examiner re-
liability, similar to the results obtained from the study
of Peterson et al. [27]. Having reached substantial
agreement between the two examiners, gives more
credibility to the results of the data collected and the
data analysis process.
Lastly, the main problems with prospective cohort
studies are modifying factors. In this particular study po-
tential modifying factors were likely to be present. These
include the fact that information about the chronicity or
the reason/cause of patients’ low back pain were not
known and are difficult to reliably distract from all pa-
tient files. However, as the study took place at a special-
ized university orthopedic hospital where difficult and
chronic cases are referred, it is safe to conclude that the
vast majority of these lumbar facet injection patients
would be in the chronic category. However, there
remained aspects of the patients that could have posi-
tively or negatively influenced the outcomes, but that we
could not evaluate with the present study. It would have
been much better if patients could have been categorized
into acute and chronic low back pain and the analyses
done separately for each group. Moreover, as already
stated above, facet joint syndrome is very difficult to
define clinically, therefore for similar future studies it
will be important to identify patients with pain really
coming from the lumbar facet joints to better evaluate
this therapeutic option.
Conclusions
Although patients without Modic changes showed a ten-
dency toward better outcomes compared to patients
with Modic changes, this did not reach statistical signifi-
cance in a fairly large patient population. Therefore, the
present study does not support the hypothesis that LBP
patients undergoing imaging-guided lumbar facet injec-
tions who also have MC type I have a less favourable
outcome from this treatment. Specifically, no statistically
and thus clinically significant results, either positive or
negative, were found when comparing patients with
MCs, either MC type I only, MC type II only or MCs
type I and II together, to patients without MCs in terms
of improvement and decreased/increased perception of
pain. Clinically, this means that the effectiveness of
therapeutic lumbar facet joint injections is not altered by
the presence or absence of MCs. More studies need to
be conducted on the importance of MCs and non-
specific LBP with other possible therapeutic options.
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